SAR 1.6
(-5.88%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|
Operating Cash Flow | 7.69 Million | 12.67 Million | 15.74 Million | 10.23 Million | 7.01 Million |
Net Income | 4.24 Million | 5.74 Million | 4.7 Million | 4.56 Million | 2.43 Million |
Depreciation & Amortization | 6.57 Million | 6.62 Million | 5.76 Million | 5.87 Million | 5.62 Million |
Deferred income taxes | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - |
Change in working capital | -5.09 Million | -561.12 Thousand | 3.86 Million | -1.41 Million | -5.05 Million |
Other non-cash items | 1.96 Million | 867.8 Thousand | 1.41 Million | 14.81 Million | 4.01 Million |
Investing Cash Flow | -11.78 Million | -20.41 Million | -14.88 Million | -921.01 Thousand | -9.26 Million |
Investments in PPE | -6.22 Million | -21.64 Million | -15.14 Million | -8.96 Million | -8.89 Million |
Acquisitions | - | 211.81 Thousand | 71.27 Thousand | 1.95 Million | - |
Investment purchases | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - |
Other Investing Activities | -5.55 Million | 1.02 Million | 187.26 Thousand | 6.08 Million | -362.7 Thousand |
Financing Cash Flow | 3.09 Million | 7.25 Million | -4.81 Million | -1.97 Million | -1.46 Million |
Debt repayment | -17.19 Million | -6.47 Million | -4.9 Million | -13.48 Million | -6.03 Million |
Dividends payments | - | - | - | - | -7.5 Million |
Common Stock Repurchased | - | - | - | - | - |
Common Stock Issuance | - | 19.67 Million | - | - | - |
Other Financing Activities | 8.83 Million | -5.94 Million | 85.95 Thousand | -14.29 Million | - |
Accounts receivables | -4.6 Million | 183.96 Thousand | 3.98 Million | -1.22 Million | -1.73 Million |
Accounts payables | - | 1.41 Million | 4.23 Million | -4.37 Million | - |
Inventory | -2.14 Million | -2.21 Million | -3.53 Million | 3.74 Million | 1.75 Million |
Other working capital | -2.94 Million | 57.33 Thousand | -804.54 Thousand | 440.75 Thousand | -5.07 Million |
Cash at beginning of period | 5.27 Million | 5.76 Million | 9.71 Million | 2.37 Million | - |
Cash at end of period | 4.28 Million | 5.27 Million | 5.76 Million | 9.71 Million | 2.37 Million |
Capital Expenditure | -6.22 Million | -21.64 Million | -15.14 Million | -8.96 Million | -8.89 Million |
Effect of forex changes on cash | - | - | - | 1.00 | 6.08 Million |
Net cash flow / Change in cash | -990.06 Thousand | -484.66 Thousand | -3.95 Million | 7.33 Million | 2.37 Million |
Free Cash Flow | 1.47 Million | -8.97 Million | 603.14 Thousand | 1.26 Million | -1.87 Million |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 784.82 Thousand | 784.82 Thousand | 898.4 Thousand | 4.24 Million | 898.4 Thousand | 1.15 Million |
Depreciation & Amortization | 1.37 Million | 1.37 Million | 1.8 Million | 6.57 Million | 1.8 Million | 1.48 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -488.31 Thousand | -488.31 Thousand | 739.15 Thousand | -5.09 Million | 739.15 Thousand | -3.84 Million |
Other non-cash items | -735.1 Thousand | -735.1 Thousand | 348.34 Thousand | 1.96 Million | 348.34 Thousand | 1.26 Million |
Investing Cash Flow | -1.44 Million | -1.44 Million | -1.45 Million | -11.78 Million | -1.45 Million | -4.43 Million |
Investments in PPE | -1.78 Million | -1.78 Million | -1.69 Million | -6.22 Million | -1.69 Million | -4.43 Million |
Acquisitions | 679.17 Thousand | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | 339.58 Thousand | 339.58 Thousand | 240 Thousand | -5.55 Million | 240 Thousand | - |
Financing Cash Flow | -258.46 Thousand | -258.46 Thousand | -2.77 Million | 3.09 Million | -2.77 Million | 4.32 Million |
Debt repayment | -590.17 Thousand | - | - | -17.19 Million | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -258.46 Thousand | -258.46 Thousand | -2.77 Million | 8.83 Million | -2.77 Million | 4.32 Million |
Accounts receivables | -1.35 Million | -1.35 Million | 2.75 Million | - | 2.75 Million | -2.33 Million |
Accounts payables | -1.68 Million | - | - | - | - | - |
Inventory | 310.68 Thousand | 310.68 Thousand | -667.33 Thousand | -2.14 Million | -667.33 Thousand | -407.16 Thousand |
Other working capital | 560.64 Thousand | 560.64 Thousand | -1.35 Million | -2.94 Million | -1.35 Million | -1.09 Million |
Cash at beginning of period | 4.28 Million | - | - | 5.27 Million | 5.17 Million | 5.27 Million |
Cash at end of period | 2.74 Million | -772.16 Thousand | -443.24 Thousand | 4.28 Million | 4.72 Million | 5.27 Million |
Capital Expenditure | -1.78 Million | -1.78 Million | -1.69 Million | -6.22 Million | -1.69 Million | -4.43 Million |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | -1.54 Million | -772.16 Thousand | -443.24 Thousand | -990.06 Thousand | -443.24 Thousand | - |
Free Cash Flow | -853.29 Thousand | -853.29 Thousand | 2.09 Million | 1.47 Million | 2.09 Million | -4.37 Million |
003025
300543
RBAZ
NSRGY
LIT
JLEN